Product name
Revaz AI
Revaz Al is a clinical decision insights system that provides accurate personalized risk management and treatment outlooks for patients with coronary artery disease (CAD). Revaz Al supports confident decision making for both clinicians and patients by forecasting the risk of health complications associated with revascularization treatments. Our artificial intelligence clinical decision support systems are ethically trained and integrate seamlessly into existing clinical workflows and clinical information software. Visit www.symbioticai.ca to learn more.The problem you are solving
We support rapid analysis of data by using artificial intelligence to support personalized CAD treatment selection and risk management at the point of care. Personalized heart care decisions lead to better health outcomes, better care, and more cost-effective and sustainable care delivery.
Study Title (long)
Discovering Revaz AI CAD Insights and User Experience for Patients and Caregivers
Intended Use & Areas of Interest
- Heart & Circulatory System
Brief description of how to use
For clinicians at a health organization, Revaz AI integrates into point of care workflows through existing electronic medical record software and cardiovascular information systems. For independent clinicians or patients, Revaz AI may be available as a web based tool that may be used to learn about CAD treatment risks. We are seeking input from patient and family caregiver partners to learn more about how we can offer the greatest value through Revaz AI insights for them. Participants will be asked to provide feedback on user experiences and the usefulness of features.
Seeking
- Evaluators
- Investors
Target Market
Canada and Outside Canada, ,
Exclusion Criteria
Age (18+)
Evaluation Period
09/12/2024 - 30/07/2025
Evaluator Sex & Age
Male Female Non-binary , From 18 to 120
Evaluator Compensation
0
Commitment of Evaluators
Participate in activities such as interviews, focus groups, and user experience testing to share your thoughts and insights about your needs, desires, and likes/dislikes of UX as a patient or caregiver of someone with Coronary Artery Disease.
Length of Follow-up (Months)
0
Story Inspiration
Coronary artery disease is a leading cause of death worldwide, but how we select treatment options is antiquated and can lead to poorer health outcomes, repeat procedures, and high care costs. We found this out through first hand experiences with family members with CAD and through our work with Cardiologists. This is why we decided to improve how we make decisions to treat CAD after a heart attack by creating Revaz AI. The first of its kind system to support personalized treatment decisions by leveraging artificial intelligence and health care data.